The commercial landscape that prompted the study is expanding rapidly. Companies exemplified by TALLY Health in the United States, co-founded by Harvard researcher David Sinclair, offer at-home kits that analyze methylation rates across the genome to produce a biological age estimate. Biological age, in this framework, is a mathematical prediction derived from biomarkers, and the gap between biological and chronological age is presented as a window into how genetics, environment and socioeconomic circumstances shape health. Many firms go further, pairing tests with anti-aging supplements containing compounds such as calcium alpha-ketoglutarate, quercetin, trans-resveratrol, spermidine and fisetin, and encouraging customers to retest repeatedly to track whether their protocols are working. While distinct from true epigenomic editing with tools like CRISPR-dCas9, these strategies similarly aim to reprogram biological processes at the molecular level, blurring the line between science, medicine and commerce.

Methodologically, the study employed a real-time Delphi approach, an iterative survey technique that lets participants see the group’s collective responses and revise their own answers asynchronously. The panel, recruited through purposive sampling from the Francophone research community, included experts in philosophy, chemistry, biology, law, sociology, geriatrics, bioinformatics and genetic discrimination, with professional experience ranging from two to twenty-one years. Of thirty-seven people invited, thirteen began the consultation and ten completed it. They rated thirteen items on a seven-point Likert scale, with a deliberately high consensus threshold of eighty percent, reflecting the ethically sensitive nature of the domain. To interpret the results, the team applied the RULE framework proposed by Matthias Wienroth, which evaluates emerging technologies through three intersecting lenses: Reliability, Utility and LEgitimacy.

On reliability, the panel voiced substantial doubt. No formal consensus was reached on any of the thirteen items, signaling persistent disagreement about the likelihood and severity of emerging problems, but the pattern of responses revealed a general climate of concern. Participants questioned whether current epigenetic tests can deliver on their promises. One panelist argued that treating biological aging as a reversible phenomenon is problematic in itself, given the complexity documented across the epigenetics literature. The study highlights that construct validity remains an active debate: many first-generation epigenetic clocks, including the widely used Horvath and Hannum models, were trained to predict chronological age, not to measure the biological processes of aging. When companies relabel this output as biological age, they may be overstating what the measurement actually captures.

The technical critique extends to measurement stability. Research by Apsley and colleagues found that many DNA methylation probes used in aging algorithms show only average or below-average stability when samples are collected repeatedly within a single five-hour window, with acute stress and early-life adversity further perturbing readings. This instability means that short-term fluctuations in estimated biological age may reflect measurement noise rather than genuine epigenetic change. Consumers who take supplements for a few months and then retest could easily misinterpret such variation as evidence that an intervention is working. The study also notes that second-generation clocks such as PhenoAge and GrimAge, which integrate clinical biomarkers and predict morbidity and mortality, offer stronger construct validity, and some companies have adopted newer models like CheekAge. Yet a 2025 systematic review found no consensus on a standardized method for assessing biological age, underscoring how immature the field remains.

On utility, the panel was split. Four participants were skeptical that knowing one’s biological age offers practical value, three viewed it positively, and three were neutral. Skeptics argued that overall health at a given age is a better indicator and suggested the tests function largely as a way of selling a service. Supporters countered that an unfavorable result might motivate healthier behavior. The discussion also examined whether epigenetic clocks can serve as surrogate endpoints in anti-aging trials, a use that Horvath and Topol caution is not yet validated because changes in epigenetic age have not been shown to reliably predict clinical outcomes. The strongest convergence in the entire consultation, item three, showed eight of ten participants rejecting the scientific justification for marketing supplements alongside epigenetic aging tests, with one panelist calling the practice a potential exploitation of people’s natural anxiety about aging.

Privacy and data governance emerged as critical flashpoints. Epigenetic data can reveal intimate insights, including disease susceptibility and estimated life expectancy, and companies have already expressed interest in using epigenetic age for life insurance underwriting. The information is also being considered for refining DNA phenotyping in forensic investigations, and researchers have warned of potential secondary uses in immigration, employment screening and military contexts. Panelists questioned who would access the data and whether confidentiality assurances could be trusted, echoing long-standing concerns about the direct-to-consumer genetic testing industry. Notably, the item calling for legislation to prevent epigenetic discrimination approached consensus with 79.21 percent stability, the closest any item came to the threshold. Panelists pointed out that existing genetic non-discrimination laws, such as those addressing genetic information in insurance, do not clearly extend to epigenetic data, leaving a regulatory vacuum.

The legitimacy dimension exposed deeper social fault lines. Panelists warned that marketing epigenetic tests as tools of personal empowerment risks shifting responsibility for aging from structural conditions onto individuals. Research by Krieger and colleagues has shown that epigenetic age acceleration is significantly associated with factors such as being born in a Jim Crow state, low parental educational attainment and adult impoverishment, conditions that disproportionately affect Black, Hispanic and socioeconomically marginalized populations. When test results strip away this structural context, accelerated aging caused by racial discrimination and economic injustice gets reframed as a personal deficit with a purchasable solution. Scholars have also warned that epigenetic responsibility narratives disproportionately target mothers and risk reinscribing racialized interpretations of biological difference. Several panelists further argued that the high cost of tests and supplements could worsen health inequities, with one observing that those who can afford repeated testing will demand more follow-up care, effectively privatizing healthcare services.

The consultation also grappled with what the commercialization of epigenetic youth does to collective perceptions of aging. Many participants felt the rhetoric reinforces ageism, pathologizes a natural process, and promotes an individualistic vision of health as capital to be maximized, with one panelist describing the phenomenon as neoliberal biocitizenship and the promise economy. Not all agreed; one participant argued that highlighting the negative aspects of aging is not morally reprehensible and that objecting to longevism is not a valid criticism. This dissent adds nuance, but the majority view held that consumer epigenomics benefits from and contributes to the commodification of longevity while obscuring the social determinants of health. The authors close with six recommendations, including improving public science communication about the limitations of current tests, regulating marketing claims about biological age, strengthening privacy protections, preventing unauthorized secondary uses of epigenetic data, organizing regular scientific guidance on clinical validity, and conducting further research with actual consumers. As epigenetic clocks migrate from laboratories to bathroom counters, the study suggests that the hardest questions are not technical but social: who benefits, who bears the burden, and whether measuring biological age will deepen or distort our understanding of what it means to grow old.

Subject of Research: Ethical, legal and social implications of direct-to-consumer epigenetic biological age testing

Article Title: Consumer epigenomics and biological age editing: ethical, legal, and social implications

Article References: Anvar, S., Dion-Labrie, M., Joly, Y., & Dupras, C. (2026). Consumer epigenomics and biological age editing: ethical, legal, and social implications. Epigenetics Communications, 6(1), Article 3. https://doi.org/10.1186/s43682-026-00044-8

Image Credits: AI Generated

DOI: 10.1186/s43682-026-00044-8

Keywords: epigenetics, biological age, DNA methylation, direct-to-consumer testing, epigenetic clocks, aging, privacy, epigenetic discrimination, health inequities, ageism, supplements, Delphi study

The analytical framework behind the study rests on two well-established pillars of organizational psychology. The first is social identity theory, originally formulated by Henri Tajfel and John Turner, which holds that people categorize themselves and others into in-groups and out-groups and then favor their own group in subtle but measurable ways. In the workplace, age functions as a powerful social identity: younger and older employees form implicit cohorts, attach stereotypes to each cohort, and interpret the same organizational events through those stereotype-tinted lenses. The second pillar is the concept of organizational climate, the shared perception employees hold about the policies, practices, and behaviors that are rewarded and expected in their organization. Prior research has shown that when the climate is inclusive of age, diversity tends to improve performance; when it is not, diversity can degrade cooperation and trust. Bennett’s study tests whether these theoretical predictions hold when younger and older American workers are asked directly about their lived experiences.

The headline finding is a strikingly symmetric perceptual divide. Older workers, those aged 50 and above, report experiencing age-based disadvantage more frequently than their younger colleagues. They describe being passed over, patronized, or assumed to lack technological fluency, consistent with a long line of research documenting ageist stereotypes that cast older employees as less adaptable, less trainable, and less valuable to invest in. Yet the same older workers are markedly more supportive of the idea that older employees should remain in the workforce for as long as they wish. In other words, the group that suffers most from age bias is also the group most committed to extended working lives, a combination that suggests older workers see continued employment as both an economic necessity and a source of identity and purpose, even while they acknowledge the friction it generates.

Younger workers tell a different story. Rather than reporting age-based exclusion, they express greater anxiety about delayed promotions and stalled career progression, a concern that researchers have long linked to perceived resource scarcity between generations. When senior positions remain occupied by employees working into their late sixties and seventies, younger workers may interpret the bottleneck as unfair competition, a dynamic documented in earlier work on intergenerational tension and subtle older-worker exclusion. The study’s results give this concern empirical weight in a nationally representative sample: younger respondents were significantly more likely than older respondents to worry that extended careers for their seniors would slow their own advancement up the organizational ladder.

A second major axis of divergence involves flexible work arrangements. Younger employees in the survey reported considerably higher engagement with flexible options, including remote work, adjustable schedules, and compressed hours, reflecting what the author characterizes as a generational shift in workplace norms rather than a simple difference in individual preference. This finding aligns with a broader body of research showing that flexibility practices interact with employee age in complex ways. Studies of hybrid and remote work have found productivity gains under geographic flexibility, while reviews of working-at-home effects note that older workers experience the health and social consequences of remote arrangements differently from younger ones. The survey data suggest that organizations offering flexibility primarily in formats designed around younger workers’ lives may unintentionally signal that these benefits belong to one cohort, reinforcing the very in-group boundaries that age-diversity programs aim to dissolve.

Perhaps the most consequential conclusion of the study is a caution against the popular corporate assumption that age diversity is automatically good for business. The analysis underscores that age diversity is not inherently beneficial; its impact depends on inclusion, climate, and proactive management. This echoes a substantial experimental and meta-analytic literature. Research on age-diversity climate has shown that age-inclusive human resource practices and the attitudes of senior leaders predict firm-level performance outcomes, while studies of age discrimination climates find negative performance consequences when bias goes unaddressed. Broader meta-analyses of workplace diversity similarly conclude that demographic differences translate into positive outcomes only under specific conditions, such as task relevance, supportive leadership, and open communication climates. The new survey results bring these laboratory and firm-level findings into the realm of ordinary workers’ perceptions, showing that the conditions for success are not yet widely met in the United States.

The practical implications for human resource leaders are concrete. Bennett points to bias-reduction strategies, inclusive flexibility policies, and cross-generational mentoring as the three most promising levers for converting potential intergenerational friction into collaborative advantage. Bias-reduction efforts draw on the intergroup contact tradition, which demonstrates through decades of meta-analysis that structured, cooperative contact between groups reduces prejudice, particularly when it unfolds under equal status and with institutional support. Mentoring programs that run in both directions, pairing older workers’ institutional knowledge with younger workers’ technological fluency, operationalize this contact principle while directly attacking the competence and warmth stereotypes that social psychology has shown people attach to both ends of the age spectrum. Inclusive flexibility, meanwhile, ensures that flexible arrangements are designed and marketed to workers of every age, preventing benefits from being coded as the property of a single generation.

The study is notable for its methodological position as one of the first nationally representative analyses to directly compare younger and older U.S. workers’ perceptions of age-related disadvantage and flexible work adoption, addressing what the author identifies as a critical gap in organizational psychology and aging research. Much of the existing evidence comes from single-firm samples, convenience surveys of older workers alone, or European datasets whose labor-market institutions differ substantially from the American context. By testing four formal hypotheses about generational differences in workplace perceptions against nationally representative data, the study provides a benchmark that future research can replicate and extend. At the same time, the cross-sectional design of the 2019 survey means the findings capture a snapshot rather than a trajectory, and the dichotomy between workers under and over 50 inevitably smooths over differences within each broad group.

Looking forward, the study closes by charting an ambitious research agenda: longitudinal designs that track how perceptions evolve as cohorts age, multi-level models that connect individual attitudes to team and organizational outcomes, and cross-cultural comparisons that test whether the American pattern of generational perception holds in societies with different retirement norms and cultural attitudes toward aging. The stakes of this agenda are rising. Labor force projections indicate that older workers will remain a growing share of the American workforce for decades, driven by longer life expectancy, changes to retirement security, and the shifting composition of available jobs. As the demographic reality of the five-generation workplace solidifies, the question is no longer whether organizations will be age-diverse but whether they will manage that diversity deliberately. The evidence from the 2019 Working Longer Survey suggests that without intentional effort, the default outcome is a workplace divided by silent, mutually reinforcing stereotypes, with older workers feeling sidelined and younger workers feeling stuck. With it, the same demographic mix could become a source of complementary skills, durable knowledge transfer, and genuine competitive advantage.

Subject of Research: Perceptions of age diversity and generational differences among younger and older U.S. workers based on the 2019 Working Longer Survey.

Article Title: Age Diversity and Workplace Perceptions: Insights from the 2019 Working Longer Survey

Article References: Bennett, J. (2026). Age Diversity and Workplace Perceptions: Insights from the 2019 Working Longer Survey. Trends in Psychology. https://doi.org/10.1007/s43076-026-00529-4

Image Credits: AI Generated

DOI: 10.1007/s43076-026-00529-4

Keywords: age diversity, workplace perceptions, generational differences, ageism, flexible work, organizational climate, social identity theory, aging workforce, inclusion, extended working lives, Diversity, Workplace